References
- Richardson C, Smith T, Schafer A, et al. Ocular motility findings in chronic progressive external ophthalmoplegia. Eye. 2005;19:258–263. doi:10.1038/sj.eye.6701488.
- Benatar M. A systematic review of diagnostic studies in myasthenia gravis. Neuromuscul Disord. 2006;16(7):459–467. doi:10.1016/j.nmd.2006.05.006.
- Hewer R, Matthews I, Chen S, et al. A sensitive non-isotopic assay for acetylcholine receptor autoantibodies. Clin Chim Acta. Febraury 2006;364(1–2):159–166. doi:10.1016/j.cccn.2005.05.035.
- McConville J, Farrugia ME, Beeson D, et al. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol. 2004;55:580–584. doi:10.1002/(ISSN)1531-8249.
- Apiwattanakul M1, McKeon A, Pittock SJ, Kryzer TJ, Lennon VA. Eliminating false-positive results in serum tests for neuromuscular autoimmunity. Muscle Nerve. 2010;41(5):702–704. doi:10.1002/mus.21653.
- Jacobson DM. Acetylcholine receptor antibodies in patients with Graves’ ophthalmopathy. J Neuro-ophthalmol. 1995;15:166–170. doi:10.1097/00041327-199509000-00008.
- Maeda Y, Nakane S, Higuchi O, et al. Ganglionic acetylcholine receptor autoantibodies in patients with autoimmune diseases including primary biliary cirrhosis. Mod Rheum. 2017;27(4):664–668.
- Doherty M, Winterton R, Griffiths PG. Eyelid surgery in ocular myopathies. Orbit. Febraury 2013;32(1):12–15. doi:10.3109/01676830.2012.736599.
- Johnson CC, Kuwubara T. Oculopharyngeal muscular dystrophy. Am J Ophthalm. 1974;77:87–89. doi:10.1016/0002-9394(74)90392-4.
- Lane CM, Collin JRO. Treatment of ptosis in chronic progressive external ophthalmoplegia. Br J Ophthal. 1987;71:290–294. doi:10.1136/bjo.71.4.290.